1. Home
  2. CISO vs XCUR Comparison

CISO vs XCUR Comparison

Compare CISO & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CISO Global Inc.

CISO

CISO Global Inc.

HOLD

Current Price

$0.26

Market Cap

13.2M

Sector

Technology

ML Signal

HOLD

XCUR

Exicure Inc.

HOLD

Current Price

$1.70

Market Cap

13.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CISO
XCUR
Founded
2015
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2M
13.7M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
CISO
XCUR
Price
$0.26
$1.70
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
443.0K
43.1K
Earning Date
05-15-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
79.31
83.37
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$1.43
52 Week High
$1.48
$9.50

Technical Indicators

Market Signals
Indicator
CISO
XCUR
Relative Strength Index (RSI) 42.78 31.68
Support Level $0.22 N/A
Resistance Level $0.32 $3.40
Average True Range (ATR) 0.02 0.27
MACD -0.00 -0.01
Stochastic Oscillator 18.94 17.77

Price Performance

Historical Comparison
CISO
XCUR

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity compliance and is a software firm composed of trained and seasoned security professionals. The services are used to protect clients' data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in the U.S., Chile, and all other countries. The maximum revenue is generated from the U.S. The products and services include: security managed services, professional services, and cybersecurity software.

About XCUR Exicure Inc.

Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.

Share on Social Networks: